by Mike Masnick
Wed, May 13th 2009 8:52am
For years, we've been among those who have questioned how the hell anyone (let alone the US Patent Office) can justify the concept of patenting genes. Yet, the Patent Office has continued to issue such patents, even as they have been shown to cause significant problems in diagnosing and treating certain illnesses. Finally, however, it appears that the concept of patenting genes is about to get tested in court. The ACLU has organized a group of cancer patients who have had treatments and medical analysis limited due to gene patents held by the company Myriad Genetics, and brought the issue to court. This is a big deal... and while the case and the resulting appeals will certainly take many years, this is going to be a case well worth watching.
If you liked this post, you may also be interested in...
- Guy Who Wants Everyone To Believe He Created Bitcoin, Now Patenting Everything Bitcoin With An Online Gambling Fugitive
- Supreme Court Says Patent Trolls Can Wait A While Before Suing
- Eli Lilly Loses Quixotic Quest To Get Canada To Pay $500 Million For Rejecting Its Bad Patents
- Confirmed: TSA's Behavioral Detection Program Is Useless, Biased, And Based On Junk Science
- ACLU Suggests Jury Instructions Might Be A Fix For 'Missing' Police Body Camera Recordings